A large U.S. health records study suggests that difficulty seeing blood in urine may put color-blind patients at higher risk.

People with color vision deficiency -- commonly known as color blindness -- may have a higher risk of mortality from bladder ...

Non-muscle invasive bladder cancer is cancer that’s only in the inner lining of your bladder. It hasn’t grown into the muscle wall. Your doctor may also call it superficial bladder cancer, urothelial ...

Protect your bladder health with these 5 essential health checks. Learn which tests and screenings you need to maintain ...

Intelligent Scopes Corp (“ISC”), specializing in state-of-the-art image enhancement and precision AI software solutions for urology and gastroenterology, is pleased to announce that CystoSmart™ has ...

In a trial, Xpert® Bladder Cancer Monitor, a non-invasive urinary biomarker test, appeared suitable for guiding cystoscopy during monitoring of patients with NMIBC. Alternating between cystoscopy and ...

New research presented at the 2025 International Kidney Cancer Symposium found that patients with localized renal cell ...

Discover a comprehensive palliative care plan designed to enhance quality of life for those with metastatic bladder cancer.

Signatera detects molecular residual disease in bladder cancer by identifying tumor DNA fragments in the bloodstream, even when not visible on scans. The IMvigor010 trial showed that Signatera-guided ...

Inlexzo is a new treatment for a type of bladder cancer in adults that hasn’t spread to the muscles and doesn’t respond to Bacillus Calmette-Guérin (BCG) therapy. It’s approved for treating non-muscle ...